FR3120787B1 - Composition pharmaceutique topique comprenant de l’amitriptyline et une phase aqueuse alcaline - Google Patents
Composition pharmaceutique topique comprenant de l’amitriptyline et une phase aqueuse alcaline Download PDFInfo
- Publication number
- FR3120787B1 FR3120787B1 FR2102760A FR2102760A FR3120787B1 FR 3120787 B1 FR3120787 B1 FR 3120787B1 FR 2102760 A FR2102760 A FR 2102760A FR 2102760 A FR2102760 A FR 2102760A FR 3120787 B1 FR3120787 B1 FR 3120787B1
- Authority
- FR
- France
- Prior art keywords
- amitriptyline
- pharmaceutical composition
- aqueous phase
- alkaline aqueous
- topical pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 title abstract 2
- 229960000836 amitriptyline Drugs 0.000 title abstract 2
- 239000008346 aqueous phase Substances 0.000 title abstract 2
- 239000012049 topical pharmaceutical composition Substances 0.000 title abstract 2
- 201000011384 erythromelalgia Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000007764 o/w emulsion Substances 0.000 abstract 1
- 239000012071 phase Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne une composition pharmaceutique topique sous forme d’émulsion huile dans eau comprenant une phase huileuse à base d’amitriptyline sous forme base et une phase aqueuse alcaline. L’invention porte également sur la composition selon l’invention pour son utilisation par voie topique dans le traitement des douleurs neuropathiques et de l’érythromélalgie.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2102760A FR3120787B1 (fr) | 2021-03-19 | 2021-03-19 | Composition pharmaceutique topique comprenant de l’amitriptyline et une phase aqueuse alcaline |
CN202280022714.5A CN117500488A (zh) | 2021-03-19 | 2022-03-15 | 包含阿米替林和碱性水相的局部药物组合物 |
EP22713714.8A EP4308093A1 (fr) | 2021-03-19 | 2022-03-15 | Composition pharmaceutique topique comprenant de l'amitriptyline et une phase aqueuse alcaline |
PCT/FR2022/050461 WO2022195214A1 (fr) | 2021-03-19 | 2022-03-15 | Composition pharmaceutique topique comprenant de l'amitriptyline et une phase aqueuse alcaline |
US18/550,908 US20240041766A1 (en) | 2021-03-19 | 2022-03-15 | Topical pharmaceutical composition comprising amitriptyline and an alkaline aqueous phase |
JP2023557355A JP2024510314A (ja) | 2021-03-19 | 2022-03-15 | アミトリプチリン及びアルカリ性水相を含む局所用医薬組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2102760A FR3120787B1 (fr) | 2021-03-19 | 2021-03-19 | Composition pharmaceutique topique comprenant de l’amitriptyline et une phase aqueuse alcaline |
FR2102760 | 2021-03-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3120787A1 FR3120787A1 (fr) | 2022-09-23 |
FR3120787B1 true FR3120787B1 (fr) | 2024-04-26 |
Family
ID=75954034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR2102760A Active FR3120787B1 (fr) | 2021-03-19 | 2021-03-19 | Composition pharmaceutique topique comprenant de l’amitriptyline et une phase aqueuse alcaline |
Country Status (6)
Country | Link |
---|---|
US (1) | US20240041766A1 (fr) |
EP (1) | EP4308093A1 (fr) |
JP (1) | JP2024510314A (fr) |
CN (1) | CN117500488A (fr) |
FR (1) | FR3120787B1 (fr) |
WO (1) | WO2022195214A1 (fr) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE32979B1 (en) | 1968-03-07 | 1974-02-06 | Unilever Ltd | Spreadable fats |
US4131576A (en) | 1977-12-15 | 1978-12-26 | National Starch And Chemical Corporation | Process for the preparation of graft copolymers of a water soluble monomer and polysaccharide employing a two-phase reaction system |
FR3065371B1 (fr) * | 2017-04-25 | 2021-05-21 | Laboratoires Mayoly Spindler | Composition pharmaceutique topique comprenant au moins de l'amitriptyline pour le traitement de douleurs neuropathiques peripheriques |
-
2021
- 2021-03-19 FR FR2102760A patent/FR3120787B1/fr active Active
-
2022
- 2022-03-15 US US18/550,908 patent/US20240041766A1/en active Pending
- 2022-03-15 WO PCT/FR2022/050461 patent/WO2022195214A1/fr active Application Filing
- 2022-03-15 JP JP2023557355A patent/JP2024510314A/ja active Pending
- 2022-03-15 EP EP22713714.8A patent/EP4308093A1/fr active Pending
- 2022-03-15 CN CN202280022714.5A patent/CN117500488A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2024510314A (ja) | 2024-03-06 |
EP4308093A1 (fr) | 2024-01-24 |
FR3120787A1 (fr) | 2022-09-23 |
WO2022195214A1 (fr) | 2022-09-22 |
CN117500488A (zh) | 2024-02-02 |
US20240041766A1 (en) | 2024-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2826292B1 (fr) | Emulsions huile dans huile comprenant une silicone, dispersions de telles emulsions et utilisation | |
BR0107042A (pt) | Dispersões para a formulação de agentes fracamente ou ligeiramente solúveis | |
TNSN99053A1 (fr) | Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant | |
EA200400765A1 (ru) | Фармацевтические составы, содержащие соединения активного витамина d | |
TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
BE1002249A4 (fr) | Compositions pharmaceutiques. | |
TNSN05262A1 (fr) | Acides carboxyliques alpha-substitues servant de modulateurs de ppar | |
FR3065371B1 (fr) | Composition pharmaceutique topique comprenant au moins de l'amitriptyline pour le traitement de douleurs neuropathiques peripheriques | |
TNSN03130A1 (fr) | Inhibiteurs de protease du vih, compositions les contenant, leurs utilisations pharmaceutiques et matieres pour leur synthese | |
TNSN96104A1 (fr) | Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant | |
PT1267832E (pt) | Sistema auto-emulsionante de libertacao de farmaco | |
FR3061010B1 (fr) | Nanoemulsions a base d'huile polaire | |
TNSN99001A1 (fr) | Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques | |
EA200301019A1 (ru) | Доставляемая перорально фармацевтическая композиция, включающая препарат с низкой растворимостью в воде (ингибитор cox-2), растворитель, жирную кислоту и органический амин | |
MA34553B1 (fr) | Combinaisons contenant du n-(2-arylamino)arylsulfonamide substitué | |
MA34158B1 (fr) | Combinaisons contenant une 2,3-dihydroimidazo{1,2-c]quinazoline substituée | |
FR3120787B1 (fr) | Composition pharmaceutique topique comprenant de l’amitriptyline et une phase aqueuse alcaline | |
FR3063645B1 (fr) | Acefapc pour le traitement des maladies acetylcholine dependantes | |
BRPI0520503A2 (pt) | composições antiinflamatórias e métodos de uso | |
DK1267831T3 (da) | Hidtil ukendt selvemulgerende system til lægemiddelindgift | |
FR3061002B1 (fr) | Composition comprenant de l’acide hydroxyethylpiperazine ethane sulfonique et au moins un alkylpolyglucoside | |
TNSN01052A1 (fr) | Metabolites du (-) - cis - 6 - phenyl - 5 - [4 -( 2-pyrrolidine -1- yl - ethoxy) - phenyl] - 5,6,7,8- tetrahydro - naphtalene - 2 - ol et compositions les contenant | |
EP1297824A3 (fr) | Emulsion ultrafine contenant un dérivé haloalkynylique | |
TNSN01076A1 (fr) | Associations de secretagogues d'hormone de croissance et d'antidepresseurs, et compositions les contenant | |
SE0102993D0 (sv) | New self emulsifying drug delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20220923 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |